DRUG vs IXJ - Compare ETFs side by side

At a glance

Comparing DRUG and IXJ. IXJ has the lower management fee at 0.4% a year, IXJ has the higher 10 years return at 9.8% a year, and DRUG offers the higher at 3.9%.

Lower fee

IXJ 0.4% p.a.

Higher 10 years return

IXJ 9.8% p.a.

Higher yield

DRUG 3.9%

Higher risk-adjusted

IXJ Sharpe 0.67 (10y)

Lower volatility

IXJ 11.5% (10y)

Larger fund

IXJ $1.5bn

Side-by-side comparison

Metric	DRUG BetaShares Global Healthcare ETF - Currency Hedged	IXJ iShares Global Healthcare ETF
Snapshot
Provider	BetaShares	iShares
Tracks index	Nasdaq Global ex-Australia Healthcare Hedged AUD Index	S&P Global 1200 Health Care Sector Index
Categories	Intl, Thematic	Intl, Thematic, Market-Cap
Listed since	—	2007 (19 yrs)
Fund size (AUM)	$172m	$1.5bn
Cost & income
Management fee	0.57%	0.4%
Dividend yield	3.9%	1.56%
Franking	0%	0%
Turnover	—	5%
Tax drag	1.25%	0.62%
Returns	Tax bracket - adjusts tax drag & net returns
1-year return	17.2% net	11.2% net
3-year return	7.3% net	6.1% net
5-year return	5.1% net	6.1% net
10-year return	8.2% net	9.8% net
Risk
Volatility (3y)	12.6%	12.6%
Volatility (5y)	13.1%	12.2%
Volatility (10y)	12.9%	11.5%
Sharpe ratio (3y)	0.3	0.2
Sharpe ratio (5y)	0.19	0.27
Sharpe ratio (10y)	0.5	0.67
Bid/ask spread	—	—

marks the strongest fund in each row. “net” shows the after-tax return at your selected bracket. “—” means we don’t have that data point yet.

Each fund at a glance

DRUG BetaShares Global Healthcare ETF - Currency Hedged

Top-15% returns over 1 year (49th of 318 ETFs we track).
Pays a useful 3.9% income yield.

Pricier than similar ETFs, which average around 0.46%.

Full DRUG analysis →

IXJ iShares Global Healthcare ETF

Low-cost: a 0.4% management fee keeps more of the return in your pocket.

Has lagged most peers over 3 years (176th of 236).

Full IXJ analysis →

Frequently Asked Questions

What's the difference between DRUG vs IXJ?

DRUG and IXJ are 2 Australian-listed ETFs we compare side by side. IXJ carries the lower management fee (0.4%). Over 10 years, IXJ has delivered the higher total return (9.8% a year). The table above breaks down fees, returns, income and risk for each.

Which has the lower fees - DRUG vs IXJ?

IXJ has the lower management fee at 0.4% a year, versus DRUG 0.57%.

Which has performed higher - DRUG vs IXJ?

Over the past 10 years, IXJ has delivered the higher total return at 9.8% a year. Past performance is not a reliable indicator of future returns.

Which pays the higher dividend yield?

DRUG pays the higher at 3.9%. Remember distributions are taxed each year at your marginal rate.

Which is the larger and most liquid?

IXJ is the larger fund by assets ($1.5bn). Larger funds are typically more liquid and trade on tighter spreads.

Related comparisons

DRUG vs CURE DRUG vs HLTH IXJ vs CURE IXJ vs IXI IXJ vs IOO IXJ vs HLTH

← Back to all ETFs

General information only, generated from each fund's published data — not personal financial advice. Past performance is not a reliable indicator of future returns. Consider your own circumstances or seek licensed advice before investing.